Abstract | OBJECTIVE: METHODS: Group A (n=20) was supported by ECMO circuits with the Minimax oxygenator and the Biomedicus centrifugal pump. Group B (n=10) was supported by ECMO circuits with the Lilliput 2 ECMO oxygenator and the Rotaflow centrifugal pump. RESULTS: ECMO circuit durability, as measured by oxygenator lifespan, was significantly better in Group B than in Group A (p = 0.04). There was significantly lower hemolysis, measured by plasma free hemoglobin, in Group B (p = 0.019), and patients in Group B had significantly less need for antithrombin III transfusion (p = 0.004). No plasma leakage was observed in Group B oxygenators, but plasma leakage was observed in all Group A oxygenators. CONCLUSION: The combination of a Rotaflow centrifugal pump and Lilliput 2 ECMO oxygenator in pediatric ECMO circuits improved durability and reduced circuit-induced hemolysis. This improvement may be due to the low priming volume, the oxygenator's plasma leakage resistance, the suspended rotor of the centrifugal pump, or a combination of these factors.
|
Authors | A P S Thiara, T N Hoel, F Kristiansen, H M Karlsen, A E Fiane, J L Svennevig |
Journal | Perfusion
(Perfusion)
Vol. 22
Issue 5
Pg. 323-6
(Sep 2007)
ISSN: 0267-6591 [Print] England |
PMID | 18416217
(Publication Type: Journal Article)
|
Chemical References |
- Anticoagulants
- Hemoglobins
- Antithrombin III
|
Topics |
- Anticoagulants
(therapeutic use)
- Antithrombin III
(therapeutic use)
- Body Size
- Cardiopulmonary Bypass
(adverse effects, instrumentation)
- Databases, Factual
- Extracorporeal Membrane Oxygenation
(adverse effects, instrumentation)
- Female
- Hemoglobins
- Hemolysis
- Humans
- Infant
- Infant, Newborn
- Infusion Pumps
- Male
- Plasma
- Retrospective Studies
- Time Factors
- Treatment Outcome
|